搜索页_+Ele+Ferrannini

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

外文资源

Elsevier电子期刊(35)

在“Elsevier电子期刊”中，命中：35条，耗时：0.1039508 秒

在所有数据库中总计命中：56条

1.LN09-2 - EMPA-REG OUTCOME^®: Macrovascular and microvascular outcomes

作者：Ele Ferrannini

刊名：Diabetes Research and Clinical Practice

出版年：2016

2.Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases

作者：Aless ; ro Antonelli ; Silvia Martina Ferrari ; Dilia Giuggioli ; Ele Ferrannini ; Clodoveo Ferri ; Poupak Fallahi

关键词：AT ; autoimmune thyroiditis ; CCL ; chemokine (C&ndash ; C motif) ligand ; CD ; cluster of differentiation ; CIA ; collagen-induced arthritis ; CS ; corticosteroid ; CSF ; cerebrospinal fluid ; CXCL ; chemokine (C&ndash ; X&ndash ; C motif) ligand ; CXCR3 ; chemokine (C&ndash ; X&ndash ; C motif) receptor 3 ; GAD ; glutamic acid decarboxylase ; GD ; Graves' disease ; GO ; Graves' ophthalmopathy ; Gtx ; hyperthyroid GD ; IFN ; interferon ; IL ; interleukin ; IP-10 ; IFN-纬-induced protein 10 ; JIA ; juvenile idiopathic arthritis ; MC ; mi

刊名：Autoimmunity Reviews

出版年：March, 2014

3.HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease

作者：C. Morgantini^a ; ^b ; D. Meriwether^c ; S. Baldi^a ; E. Venturi^a ; S. Pinnola^a ; A.C. Wagner^c ; A.M. Fogelman^c ; E. Ferrannini^a ; A. Natali^a ; S.T. Reddy^c ; ^d ; ^{sreddy@mednet.ucla.edu" class="auth_mail}

关键词：HDL ; Lipid composition ; Atherosclerosis ; Type 2 diabetes

刊名：Nutrition, Metabolism and Cardiovascular Diseases

出版年：June 2014

4.Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus

作者：Vivian A. Fonseca^a ; ^{vfonseca@tulane.edu} ; Ele Ferrannini^b ; John P. Wilding^c ; Wim Wilpshaar^d ; Perminder Dhanjal^d ; Greg Ball^e ; Sally Klasen^e

关键词：Ipragliflozin ; Sodium glucose co-transporter 2 (SGLT2) inhibitor ; Hyperglycemia ; Glucose ; Diabetes

刊名：Journal of Diabetes and its Complications

出版年：2013

5.Interferon-¦Á, -¦Â and -¦Ã induce CXCL11 secretion in human thyrocytes: Modulation by peroxisome proliferator-activated receptor ¦Ã agonists

作者：Alessandro Antonelli^a ; ^{alessandro.antonelli@med.unipi.it} ; Silvia Martina Ferrari^a ; Caterina Mancusi^a ; Valeria Mazzi^a ; Cinzia Pupilli^b ; Marco Centanni^c ; Clodoveo Ferri^d ; Ele Ferrannini^a ; Poupak Fallahi^a

关键词：CXCL ; chemokine C&ndash ; X&ndash ; C motif ligand ; CXCR ; CXC chemokine receptor ; IFN ; interferon ; Th ; T-helper ; AITD ; autoimmune thyroid disorders ; TNF ; tumor necrosis factor ; PPAR ; peroxisome proliferator-activated receptor ; RGZ ; rosiglitazone ; ANOVA ; analy

刊名：Immunobiology

出版年：2013

6.Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis¡¯s MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokine

作者：Andrea Cossu^a ; Ele Ferrannini^b ; Poupak Fallahi^b ; Alessandro Antonelli^b ; Leonardo A. Sechi^a ; ^{sechila@uniss.it}

关键词：T1DM ; type 1 diabetes mellitus ; Map ; Mycobacterium avium subsp paratuberculosis ; ELISA ; Enzyme-linked-ImmunoSorbent-Assay

刊名：Cytokine

出版年：2013

7.Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer

作者：Alessandro Antonelli^a ; ^{alessandro.antonelli@med.unipi.it} ; Silvia Martina Ferrari^a ; ^{sm.ferrari@int.med.unipi.it} ; Poupak Fallahi^a ; ^{poupak@int.med.unipi.it} ; Simona Piaggi^b ; ^{simona.piaggi@dps.unipi.it} ; Andrea Di Domenicantonio^a ; ^{didomand@libero.it} ; David Galleri^c ; ^{galleridavid@hotmail.com} ; Libero Santarpia^d ; ^{lsantarpia@usl4.toscana.it} ; Fulvio Basolo^c ; ^{f.basolo@med.unipi.it} ; Ele Ferrannini^a ; ^{ferranni@ifc.cnr.it} ; Paolo Miccoli^c ; ^{p.miccoli@dc.med.unipi.it}

关键词：ANA ; primary ATC cells cultures ; ATC ; anaplastic thyroid cancer ; BCA ; bicinchoninic acid ; CXCL ; chemokine (C&ndash ; X&ndash ; C motif) ligand ; CXCR ; CXC chemokine receptors ; ELISA ; enzyme-linked immunosorbent assay ; EMA ; European medicine agency ; EMSA ; elect

刊名：Cytokine

出版年：2012

8.Peroxisome proliferator-activated receptor-¦Á agonists modulate CXCL9 and CXCL11 chemokines in Graves?ophthalmopathy fibroblasts and preadipocytes

作者：Alessandro Antonelli^a ; ^{alessandro.antonelli@med.unipi.it} ; Silvia Martina Ferrari^a ; ^{sm.ferrari@int.med.unipi.it} ; Silvia Frascerra^a ; ^{lafrasce@gmail.com} ; Ilaria Ruffilli^a ; ^{ilaria.ruffilli@gmail.com} ; Stefania Gelmini^b ; ^{s.gelmini@dfc.unifi.it} ; Michele Minuto^c ; ^{micheleminuto@hotmail.com} ; Cinzia Pupilli^d ; ^{c.pupilli@dfc.unifi.it} ; Paolo Miccoli^c ; ^{p.miccoli@dc.med.unipi.it} ; Stefano Sellari-Franceschini^e ; ^{s.sellari@ent.med.unipi.it} ; Ele Ferrannini^a ; ^{ferranni@ifc.cnr.it} ; Poupak Fallahi^a ; ^{poupak@int.med.unipi.it}

关键词：PPAR ; peroxisome proliferator-activated receptors ; IL ; interleukin ; CXCL ; chemokine (C&ndash ; X&ndash ; C motif) ligand ; GO ; Graves&rsquo ; ophthalmopathy ; GD ; Grave&rsquo ; s disease ; RGZ ; rosiglitazone ; GAPDH ; glyceraldehyde 3-phosphate dehydrogenase

刊名：Molecular and Cellular Endocrinology

出版年：2012

9.Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population

作者：Wolfram Doehner^a ; ^b ; ^{wolfram.doehner@charite.de} ; Erland Erdmann^c ; Richard Cairns^d ; Andrew L. Clark^e ; John A. Dormandy^f ; Ele Ferrannini^g ; Stefan D. Anker^b ; ^h

关键词：Body weight ; Weight loss ; Diabetes ; Pioglitazone ; Risk ; Prognosis

刊名：International Journal of Cardiology

出版年：2012

10.Physiology of Glucose Homeostasis and Insulin Therapy in Type 1 and Type 2 Diabetes

作者：Ele Ferrannini ; MD ^{ferranni@ifc.cnr.it}

关键词：Type 2 diabetes ; Type 1 diabetes ; Glucose homeostasis ; Insulin therapy

刊名：Endocrinology and Metabolism Clinics of North America

出版年：2012

按检索点细分(35)

作者(34)

按出版年细分(35)

2027年及以后(2)

2016年(1)

2013年(3)

2012年(6)

2011年(5)

2010年(2)

2009年(1)

2008年(3)

2007年(1)

2006年(2)

2005年(1)

2004年(1)

2003年(1)

2000年(1)

2000年及以前(5)